Given that dysregulation of the JNK signaling pathway is implicated in a broad range of diseases (Yan et al. 2024), including metabolic disorders, neurological conditions, and cancer, targeting this pathway could offer a promising therapeutic strategy. The gene discussed is MAPK8; the disease is metabolic disease.